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Abstract
We conducted a group randomized trial to assess the feasibility and effectiveness of a multi-
component, clinic-based HIV prevention intervention for HIV-positive patients attending clinical 
care in Namibia, Kenya, and Tanzania. Eighteen HIV care and treatment clinics (six per country) 
were randomly assigned to intervention or control arms. Approximately 200 sexually active clients 
from each clinic were enrolled and interviewed at baseline and 6- and 12-months post-
intervention. Mixed model logistic regression with random effects for clinic and participant was 
used to assess the effectiveness of the intervention. Of 3522 HIV-positive patients enrolled, 3034 
(86 %) completed a 12-month follow-up interview. Intervention participants were significantly 
more likely to report receiving provider-delivered messages on disclosure, partner testing, family 
planning, alcohol reduction, and consistent condom use compared to participants in comparison 
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clinics. Participants in intervention clinics were less likely to report unprotected sex in the past 2 
weeks (OR = 0.56, 95 % CI 0.32, 0.99) compared to participants in comparison clinics. In 
Tanzania, a higher percentage of participants in intervention clinics (17 %) reported using a highly 
effective method of contraception compared to participants in comparison clinics (10 %, OR = 
2.25, 95 % CI 1.24, 4.10). This effect was not observed in Kenya or Namibia. HIV prevention 
services are feasible to implement as part of routine care and are associated with a self-reported 
decrease in unprotected sex. Further operational research is needed to identify strategies to address 
common operational challenges including staff turnover and large patient volumes.
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Introduction
Over the past 30 years, remarkable progress has been made in curbing the HIV epidemic. 
From 2001 to 2013, annual incidence of new HIV infections decreased by 38 % and AIDS-
related deaths decreased by 35 % [1]. Despite this progress, HIV remains a significant public 
health burden in many countries, with 2.1 million individuals newly infected with HIV in 
2013 [1]. Sub-Saharan Africa remains the most heavily affected region, accounting for 70 % 
of all new infections and 71 % of the estimated 36.9 million people living with HIV 
(PLHIV) globally [1].
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has released several 
ambitious goals to help end the global HIV epidemic. The first set of goals, known as the 
90–90–90 goals, aim to strengthen the HIV care continuum [2]. These goals state that by 
2020: 90 % of all PLHIV will know their HIV status; 90 % of all people with diagnosed 
HIV infection will receive sustained antiretroviral therapy (ART); and 90 % of all people 
receiving ART will achieve viral suppression [2]. Similarly, an HIV prevention goal aims to 
reduce the number of new HIV infections worldwide to less than 500,000 by 2020 and to 
less than 200,000 by 2030 [3]. Achieving these goals will require scaling up both treatment 
and prevention efforts as well as focusing on key and priority populations including PLHIV.
Prevention interventions for PLHIV integrated into facility and community-based ART 
programs can dramatically reduce sexual transmission of HIV and effectively engage 
PLHIV as equal partners in efforts to curb the HIV epidemic [4]. Evidence-based prevention 
interventions for PLHIV include: adherence counseling and support, risk reduction 
counselling and condom provision, partner HIV testing and counseling, family planning 
counseling and services, and STI treatment and management [5]. These interventions also 
provide a supportive framework for achieving the 90–90–90 goals by facilitating diagnosis 
of PLHIV through a focus on testing the partner(s) and children of HIV-positive individuals 
(first 90); retention in HIV care and treatment programs by addressing the sexual and 
reproductive health needs of PLHIV (second 90); and viral suppression through adherence 
counselling and support (third 90).
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Evidence from U.S. settings indicates that provider delivered HIV prevention services can 
effectively reduce sexual risk behavior [6, 7], STI incidence [8, 9], and unintended 
pregnancy among PLHIV [10]. However, data from sub-Saharan Africa are limited. Clinics 
in these regions face operational challenges not experienced in the U.S. including inadequate 
staffing, large patient volumes, and poor recordkeeping [11]. To address this knowledge gap, 
this manuscript reports the results of a group randomized trial examining the feasibility and 
effectiveness of a clinic-based package of HIV prevention interventions delivered to PLHIV 
attending clinical care in three sub-Saharan African countries.
Methods
This study was conducted in 18 HIV clinics in Kenya, Namibia, and Tanzania (six per 
country). Clinics were matched on clinic-level factors (e.g. provider/patient ratio, number of 
patients enrolled, and clinical services provided) and then randomly assigned to either the 
intervention or a wait-list comparison arm. In the comparison arm, providers delivered 
services according to their usual standard of care. Following final study data collection, 
providers in the comparison clinics were trained to deliver the HIV prevention services as 
described below.
Objectives and Hypotheses
The main objective of this study was to evaluate the effectiveness of integrating HIV 
prevention interventions into routine HIV care and treatment services in resource-limited 
settings. Project hypotheses focused on the effectiveness of these prevention interventions at 
impacting behavioral outcomes (i.e. decreased unprotected vaginal sex, decreased alcohol 
use, increased HIV serostatus disclosure and partner testing, and increased adherence to 
anti-retroviral (ARV) medications), biologic outcomes (i.e. decreased unintended 
pregnancy), and service delivery outcomes (i.e. provision of family planning counseling and 
services) comparing intervention and comparison clinics, with intervention participants 
hypothesized to report lower risk behavior than comparison participants after 12-months of 
follow-up. A secondary objective was to assess the feasibility and acceptability of 
integrating the prevention interventions into HIV clinical settings.
Intervention
In the intervention arm, health care providers (HCPs) received a 1 week training on how to 
deliver prevention messages on HIV serostatus disclosure, alcohol and sexual risk reduction, 
partner HIV testing, medication adherence, and family planning (Fig. 1). Providers were also 
trained to distribute condoms to patients at every clinic visit. Research staff worked with 
HCPs to ensure a continuous supply of condoms to prevent condom stock-outs. Participants 
who did not desire pregnancy were encouraged to use condoms plus another form of highly 
effective contraception per current World Health Organization (WHO) guidelines [12]. To 
improve patients’ access to short-acting hormonal contraceptives, pills and injectables were 
offered at the HIV clinic. Providers referred patients desiring longer-acting contraceptive 
methods (e.g., intrauterine devices, implants) to family planning clinics.
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Lay counselors (LCs) received a 2-week training on how to support and reinforce provider-
delivered HIV prevention services through group education (see Fig. 1) and individual 
counseling sessions. Counselors in Namibia and Kenya were also trained to conduct partner 
and couples HIV testing and counseling. In Tanzania, LCs only provided pre- and post-test 
counseling as they were not permitted by national guidelines to conduct HIV testing.
Trainings in all three countries were conducted by the same group of trainers using a written 
curriculum.
Procedures
At each of the 18 study clinics, a representative sample of approximately 200 sexually active 
patients was enrolled as part of an evaluation cohort to assess the effectiveness of the clinic-
level intervention. The primary outcome variable for the study was self-report of any 
unprotected sex in the past 3 months. Sample size calculations assumed a rate of at least 
50 % for any unprotected sex in the past 3 months for the comparison condition. Sample size 
estimates took into account expectations of attrition in the project cohort, which was 
expected to be moderate (at most 30 % at the 12-month follow-up). Sample size estimates 
were calculated using a formula developed by Murray for group-randomized trials [13]. 
Using this formula, it was determined that the project would have at least 80 % power to 
detect a 25 % difference between intervention and comparison arms (absolute difference of 
12.5 %, with an intra-class coefficient of 0.02) with 9 clinics per condition, each with 200 
patients enrolled.
Procedures for patient enrollment have been previously described [14]. In brief, study staff 
approached every third patient in the clinic waiting area and asked if he/she was interested in 
participating in the study. Interested patients were taken to a private area, told about the 
project, and screened for eligibility. Patients were eligible for inclusion if they were over 18 
years of age, received HIV clinical care at the study clinic at least twice, reported being 
sexually active within the past 3 months, and planned to attend the clinic for at least a year. 
Women who knew they were pregnant and male partners of pregnant women were excluded.
Study staff administered questionnaires to patients at baseline and at 6- and 12-months post-
intervention. Data collection start dates were staggered across countries with each data 
collection period taking approximately 3 months. Baseline data collection began in October 
2009 and was completed by April 2010. All data collection was completed by December 
2011. Participants who failed to keep a scheduled appointment were traced by study staff 
using phone calls, text messages or clinic defaulter staff.
Measures and Sources of Data
Observations of HCP and LC Patient Interactions—Study staff observed patient 
encounters with HCPs and LCs using a standardized observation form (see Table 2 for 
specific topics). Random days during the month were chosen to conduct the observations. 
Observations were conducted with patients who were and were not enrolled in the study 
since HCPs and LCs were trained to provide services to all patients in the clinic (not just 
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those in the study). Approximately 3 % of clinic visits were observed throughout the 
intervention period.
Health Care Provider Questionnaires—At baseline and 6- and 12-months post-
intervention, HCPs in all clinics were asked to rate the feasibility and importance of offering 
HIV prevention services to patients during routine visits and to rate how comfortable they 
were discussing prevention issues with patients. They were also asked if patients were 
comfortable receiving prevention information from them. All responses were on a 5-point 
Likert scale with higher scores indicating stronger agreement or greater comfort.
Patient Questionnaires—Sociodemographic variables included age, gender, education, 
and paid work in the past 6 months. Participants provided the name and dose of their HIV 
medications and indicated whether they had missed any doses in the last 30 days. 
Participants were asked to name up to five sex partners in the past 3 months. For each named 
partner, participants were asked whether the partner was a spouse, main, or non-main partner 
and whether they had unprotected sex at last vaginal sex and/or within the past 2 weeks with 
the partner. Participants indicated whether they had disclosed their HIV status to the partner, 
whether the partner had been tested for HIV and if so, whether the participant knew the 
partner’s HIV status. To assess pregnancy intention, participants were asked whether they 
were pregnant or desired a pregnancy in the next 6 months (female) or whether they desired 
their spouse or main partner to become pregnant in the next 6 months (male). They were also 
asked whether they (or their partner) were using condoms and/or a highly effective 
contraceptive method [e.g., pills, injectable, intra-uterine device (IUD), implant, male or 
female sterilization] to prevent pregnancy. The 10-item Alcohol Use Disorders Identification 
Test (AUDIT) [15] was used to categorize participants as non-drinkers (AUDIT = 0), non-
problem drinkers (AUDIT 1–8), problem drinkers (AUDIT 8–12 for women, 8–14 for men), 
and likely dependent on alcohol (AUDIT ≥13 for women, ≥15 for men). The AUDIT has 
been widely used and validated in a variety of settings throughout sub-Saharan Africa [16–
19].
Medical Chart and Clinic Record Abstraction—Data abstracted from patient medical 
charts included date of HIV diagnosis, dates of HIV clinic visits in the past 6 months, most 
recent CD4 count, prescribed HIV medications and dosages, and pregnancy status. Number 
of contraceptive pills and injections delivered to women in the study clinics were abstracted 
from clinic registers.
Data Analysis
Baseline sociodemographic and HIV-related variables of interest were compared using the 
GLIMMIX procedure in SAS 9.3 to fit mixed model logistic regressions with trial arm as the 
dependent variable and the variable of interest as the independent variable. All models 
included a random effect for clinic to adjust for within-clinic correlation. For the outcome 
analyses, GLIMMIX models were used with fixed effects for country, time (6 or 12 month 
follow-up), trial arm (intervention or standard of care) and all possible interactions, and 
random effects for clinic and participant (to control for correlation within clinic and within 
person over time). The baseline value for the outcome of interest was included as a covariate 
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in these models, both to control for baseline differences across arms and to reduce the 
intraclass correlation coefficient, where possible. When interaction terms were significant, 
odds ratios were estimated within country and/or time. When no interaction terms were 
significant, these were dropped from the model, and if there were no intervention effects, we 
tested for a significant time effect (modeling baseline as one of the timepoints instead of as a 
covariate).
Ethical Considerations
The study protocol was approved by ethics review committees at the U.S. Centers for 
Disease Control and Prevention and at all collaborating organizations including the 
Columbia University Medical Center, Kenya Medical Research Institute (KEMRI), Namibia 
Ministry of Health and Social Services (MOHSS), Tanzania National Institute of Medical 
Research (NIMR), and the Zanzibar Medical Ethical Committee (ZAMEC). All patients, 
health care providers, and lay counselors signed written informed consent forms prior to the 
start of data collection procedures.
Results
A total of 3538 HIV-positive patients were enrolled between September 2009 and April 
2010. Sixteen patients were removed from the analysis because the gender recorded at the 
baseline and follow-up interviews did not match, leading to uncertainty whether the same 
person had completed all interviews. This left an analytic sample of 3522 HIV positive 
patients (intervention: 1778; comparison: 1744) (Fig. 2). The majority of participants (58 %) 
were female (Table 1). Nearly half were between 30 and 39 years of age with a median age 
of 36 years. Male participants were significantly older than female participants (median age: 
41 vs. 35 years, p <0.0001). Most had completed primary (53 %) or secondary (34 %) 
school although 10 % reported receiving no schooling. Less than half (44 %) reported 
having paid work in the last 6 months. Sixty-one percent were married or cohabiting, with 
nearly all (95 %) reporting only one sex partner in the past 90 days.
Twenty-six percent had been diagnosed with HIV within the past year and 70 % within the 
past 3 years (Table 1). Nearly a quarter had a CD4 count less than 200 cells/mm3 at their last 
test and another 30 % had a CD4 count between 200 and 349 cells/mm3. Sixty-four percent 
of participants were on ART at the time of enrollment. By the 12-month follow-up, 81 % 
were on ART. There were no significant differences between trial arms on any of these 
demographic or clinical variables. Overall, 86 % of participants (84 % in the intervention 
group, 89 % in the comparison group; OR = 0.65, 95 % CI 0.47, 0.91) were retained in the 
study through the 12-month follow-up assessment.
Implementation of the Intervention
Table 2 summarizes the extent to which the intervention was delivered by HCPs during 
observations of provider-patient interactions. Providers in the intervention clinics more 
frequently discussed safer sex (45 % vs. 31 %, p = 0.03), consistent condom use (62 % vs. 
45 %, p = 0.05), and patients’ use of alcohol (54 % vs. 34 %, p = 0.005) than providers in 
comparison clinics. They were also more likely to assess whether participants had disclosed 
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their HIV status to a sex partner (40 % vs. 27 %, p = 0.002). There was a significant country 
by trial arm interaction on discussion of partner testing with providers in intervention clinics 
in Kenya (84 % vs. 66 %, p = 0.0003) and Namibia (39 % vs. 8 %, p <0.0001) more likely to 
discuss partner testing than in comparison clinics. There was a similar but non-significant 
trend on this variable in Tanzania (72 % vs. 54 %, p = 0.23).
During interviews, participants in intervention clinics were more likely to report receiving 
prevention messages from their HCPs compared to participants in comparison clinics at the 
12-month follow-up (data not shown). This includes messages on disclosure (78 % vs. 62 %, 
p = 0.04), partner testing (80 % vs. 61 %, p = 0.02), family planning (67 % vs. 47 %, p = 
0.002), alcohol reduction (88 % vs. 72 %, p = 0.005), and consistent condom use (97 % vs. 
86 %, p <0.0001). Overall 31 % of study participants in intervention clinics reported 
meeting with a LC at the 6 month assessment, which increased to 52 % at the 12 month 
assessment. In the 3878 interactions observed, LCs consistently delivered HIV prevention 
messages to patients including messages on safer sex (77 % of sessions), consistent condom 
use (85 %), alcohol use (81 %), HIV serostatus disclosure (87 %), and partner testing 
(81 %).
LCs distributed condoms to patients in 62 % of observed encounters. HCPs distributed 
condoms to patients in 29 % of observed encounters in intervention clinics compared to 
13 % in comparison clinics (p = 0.10). Family planning services were provided more 
frequently in intervention than comparison clinics (18 % vs. 13 %, p = 0.04). Clinic records 
indicate that significantly more oral contraceptive pills (mean average: 16.4 pill packs per 
month vs. 3.0 per month, p = 0.003) and injectables (18.4 vs. 4.3, p = 0.002) were provided 
in intervention clinics compared to comparison clinics.
Intervention Outcome Analyses
Table 3 compares the outcome variables between the intervention and comparison groups at 
the baseline, 6-month, and 12-month follow-up periods. Participants in intervention clinics 
were less likely to report unprotected sex in the past 2 weeks (OR = 0.56, 95 % CI 0.32, 
0.99) compared to participants in comparison clinics. A smaller percentage of participants in 
the intervention clinics in Tanzania reported unprotected sex at last sex compared to 
participants in comparison clinics (OR = 0.23, 95 % CI 0.14, 0.40, p <0.0001). This effect 
was not observed in participants from Namibia and Kenya. Similarly, participants in 
intervention clinics in Tanzania were more likely to report using a highly effective method of 
contraception compared to participants in comparison clinics (10 %, OR = 2.25, 95 % CI 
1.24, 4.10, p = 0.0097). This effect was not observed in Kenya or Namibia.
There was no significant difference by trial arm on any of the remaining variables including 
alcohol use, medication adherence, HIV serostatus disclosure, and partner testing (Table 3). 
The rate of new pregnancies also did not differ significantly between intervention and 
comparison clinics (55 and 58 pregnancies, respectively).
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This paper presents findings from a longitudinal, multi-country study examining the impact 
of integrating HIV prevention interventions into routine clinical care for PLHIV in sub-
Saharan Africa. Study findings demonstrate that integrated prevention services are feasible 
to implement as part of routine care. During observations of patient-provider interactions, 
providers in intervention clinics were more likely to discuss HIV prevention messages with 
their patients compared to providers in comparison clinics. In addition, during follow-up 
interviews, participants in intervention clinics were more likely to report receiving 
prevention services from their providers.
Despite this high level of integration, effects on behavior change were minimal. Participants 
in intervention clinics from all three countries were less likely to report unprotected sex in 
the past 2 weeks. In addition, Tanzanian participants in intervention clinics were less likely 
to report unprotected sex at last sex and more likely to report using a highly effective method 
of contraception. These effects were not observed in participants from Namibia and Kenya. 
Several factors may account for these country-level differences. Among the three countries, 
Tanzanian participants reported the lowest rates of condom use and hormonal contraception 
at baseline. In addition, at the time this study was implemented, both Kenya and Namibia 
had national policies supportive of delivering prevention interventions within HIV clinical 
settings. Factors such as national policies, laws, and cultural norms have been shown to have 
a strong influence on health behaviors [20] and may help explain some of the observed 
differences in this study.
Other factors may also have contributed to the limited impact on behavior change observed 
in this study. First, high baseline rates were observed on many outcome variables including 
condom use, disclosure, and knowledge of partner status. This study relied largely on patient 
self-report and patients may have over-reported their behavior on these variables. This over-
reporting should have affected both study arms equally due to the randomization process. 
However, the high baseline rates may have created a ceiling effect and limited the ability of 
the study to show improvement over time on key variables. In addition, staff turnover was 
frequent. While we attempted to continually train new providers in the intervention clinics, 
participants may have been seen by untrained providers. Moreover, this was a clinic-level 
intervention that encouraged providers to refer patients to LCs for additional counseling and 
support. While the percent of participants who reported meeting with a LC did increase over 
the course of the study, not all participants met with a LC and, thus, were not exposed to 
additional individualized HIV prevention counseling.
This intervention included multiple components targeting a number of different behaviors. 
Offering all of these services at every clinic visit may not be feasible given the wide range of 
operational challenges experienced in these settings including large patient volumes, 
inadequate staffing, and frequent staff turnover [11]. Further research is needed to determine 
the optimal service delivery model for delivering prevention interventions to PLHIV within 
facility settings. In addition, recent research indicates that community-based organizations 
can increase the awareness, availability, and utilization of facility-based HIV services as well 
as effectively deliver many prevention, care, and support activities [21, 22]. Delivery of 
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community-based HIV services can reduce patient burden within facility settings, leading to 
shorter wait times and allowing clinicians to focus on patients with complex medical needs. 
Operational research to explore delivery of prevention interventions for PLHIV within 
community settings is therefore urgently needed.
In conclusion, this study found that HIV prevention services are feasible to implement as 
part of routine care and result in more provider-delivered HIV prevention messages. The 
intervention led to a self-reported decrease in unprotected sex in the past 2 weeks. However, 
no change was observed in more objective measures of sexual activity. Therefore, it remains 
uncertain whether sexual behavior truly changed or not. On other measures, the data were 
insufficient to determine whether the intervention had its desired impact. Strategies to 
address operational challenges including high staff turnover and large patient volumes will 
need to be identified. Further operational research, ideally with biomarkers and costing 
information, is also needed to determine optimal service delivery models for delivering 
prevention interventions to PLHIV in diverse resource-limited settings.
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Summary of model for integrating HIV prevention messages and services into the routine 
care offered to HIV-positive patients attending clinical care in Kenya, Tanzania, and 
Namibia
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Flow diagram showing follow-up of HIV-positive patients enrolled in a group randomized 
control trial. Note Unable to interview includes unable to locate, transferred to another 
clinic, and declined interview
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Table 1
Baseline sociodemographic and health characteristics of study participants
Overall (n = 3522)
n (%)
Intervention (n = 1778)
n (%)




 Male 1476 (41.9) 761 (42.8) 715 (41.0)
 Female 2046 (58.1) 1017 (57.2) 1029 (59.0)
Age, years .7267
 18–29 615 (17.5) 317 (17.8) 298 (17.1)
 30–39 1659 (47.1) 822 (46.2) 837 (48.0)
 40–49 974 (27.7) 490 (27.6) 484 (27.8)
 ≥50 274 (7.8) 149 (8.4) 125 (7.2)
Education .9174
 No school 340 (9.7) 176 (9.9) 164 (9.4)
 Primary school 1883 (53.4) 943 (53.1) 940 (54.0)
 Secondary school 1206 (34.3) 598 (33.7) 608 (34.9)
 More than secondary school 88 (2.5) 58 (3.3) 30 (1.7)
Any paid work, past 6 months 1559 (44.3) 777 (43.8) 782 (44.9) .9177
Marital status .7962
 Married/living together 2161 (61.4) 1123 (63.2) 1038 (59.5)
 Single, never married 775 (22.0) 353 (19.9) 422 (24.2)
 Separated / divorced 359 (10.2) 206 (11.6) 153 (8.8)
 Widowed 225 (6.4) 94 (5.3) 131 (7.5)
Have children 3181 (90.3) 1603 (90.2) 1578 (90.5) .8321
On antiretrovirals 2259 (64.2) 1163 (65.5) 1096 (62.8) .2561
Years since HIV diagnosis .2423
 <1 years 923 (26.2) 532 (29.9) 391 (22.4)
 1 to <2 years 803 (22.8) 411 (23.1) 392 (22.5)
 2 to < 3 years 719 (20.4) 357 (20.1) 362 (20.8)
 ≥3 years 1075 (30.5) 477 (26.8) 598 (34.3)
Most recent CD4 count (per mm3) <.0001
 <200 822 (23.6) 486 (27.7) 336 (19.4)
 200–349 1035 (29.7) 518 (29.5) 517 (29.9)
 350–500 793 (22.8) 367 (20.9) 426 (24.6)
 ≥501 834 (23.9) 383 (21.8) 451 (26.1)
Note Percentages may not total to 100% due to rounding
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